me.beaulieu
Submits third-party assay reports on material purchased directly. Based in Lublin.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
7
n=7
Annotations
0
n=0
Median purity submitted
99.04%
n=7
Suppliers covered
7
n=7
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042489 | N-Acetyl Semax Amide | Homopeptide | HOMO-2603-C5267 | VendorInvestigate | 2026-Q2 | 99.34 | 8.29 | 98.2 | Buyer-sourced | 0 | PASS |
| AX-2026-041688 | Semaglutide | TFS | TFS-{CAT}-9744 | Medutest | 2026-Q2 | 98.17 | 5.60 | — | Buyer-sourced | 0 | PASS |
| AX-2026-042653 | CJC-1295 (no DAC) | SWB | SWB-2512-S8187 | Medutest | 2026-Q1 | 99.04 | 3.94 | — | Buyer-sourced | 0 | PASS |
| AX-2025-019576 | Tirzepatide | TFC | TFC-2507-T1116 | Janoshik | 2025-Q3 | 98.22 | 3.62 | 101.8 | Buyer-sourced | 0 | PASS |
| AX-2025-018772 | MK-677 (Ibutamoren mesylate) | FGP | FGP-2502-F7880 | Janoshik | 2025-Q2 | 99.23 | 4.54 | 95.0 | Buyer-sourced | 0 | FAIL |
| AX-2025-020205 | Oxytocin | ERP | ERP-2503-A9615 | PeptideMeter | 2025-Q2 | 98.98 | 4.91 | — | Buyer-sourced | 0 | PASS |
| AX-2024-004485 | BPC-157 | HYB | HYB-2409-X6061 | Janoshik | 2024-Q4 | 99.14 | 3.78 | — | Buyer-sourced | 2 | MARGINAL |